[HTML][HTML] Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a …
FJ Lavalle-González, A Januszewicz, J Davidson… - Diabetologia, 2013 - Springer
Aims/hypothesis The aim of this work was to evaluate the efficacy and safety of canagliflozin
vs placebo and sitagliptin in patients with type 2 diabetes who were being treated with …
vs placebo and sitagliptin in patients with type 2 diabetes who were being treated with …
[HTML][HTML] Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a …
FJ Lavalle-González, A Januszewicz, J Davidson… - Diabetologia, 2013 - ncbi.nlm.nih.gov
Methods This randomised, double-blind, four-arm, parallel-group, Phase 3 study was
conducted at 169 centres in 22 countries between April 2010 and August 2012. Participants …
conducted at 169 centres in 22 countries between April 2010 and August 2012. Participants …
[PDF][PDF] Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised …
FJ Lavalle-González, A Januszewicz, J Davidson… - Diabetologia, 2013 - cyberleninka.org
Aims/hypothesis The aim of this work was to evaluate the efficacy and safety of canagliflozin
vs placebo and sitagliptin in patients with type 2 diabetes who were being treated with …
vs placebo and sitagliptin in patients with type 2 diabetes who were being treated with …
Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial
FJ Lavalle-González, A Januszewicz, J Davidson… - Diabetologia, 2013 - hero.epa.gov
AIMS/HYPOTHESIS: The aim of this work was to evaluate the efficacy and safety of
canagliflozin vs placebo and sitagliptin in patients with type 2 diabetes who were being …
canagliflozin vs placebo and sitagliptin in patients with type 2 diabetes who were being …
[PDF][PDF] Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised …
FJ Lavalle-González, A Januszewicz, J Davidson… - Diabetologia, 2013 - researchgate.net
Aims/hypothesis The aim of this work was to evaluate the efficacy and safety of canagliflozin
vs placebo and sitagliptin in patients with type 2 diabetes who were being treated with …
vs placebo and sitagliptin in patients with type 2 diabetes who were being treated with …
Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial
FJ Lavalle-González, A Januszewicz… - …, 2013 - pubmed.ncbi.nlm.nih.gov
Aims/hypothesis The aim of this work was to evaluate the efficacy and safety of canagliflozin
vs placebo and sitagliptin in patients with type 2 diabetes who were being treated with …
vs placebo and sitagliptin in patients with type 2 diabetes who were being treated with …
Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial
FJ Lavalle-González, A Januszewicz, J Davidson… - Diabetologia, 2013 - infona.pl
Aims/hypothesis The aim of this work was to evaluate the efficacy and safety of canagliflozin
vs placebo and sitagliptin in patients with type 2 diabetes who were being treated with …
vs placebo and sitagliptin in patients with type 2 diabetes who were being treated with …
[引用][C] Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised …
FJ LAVALLE-GONZALEZ… - Diabetologia …, 2013 - pascal-francis.inist.fr
Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with
type 2 diabetes on background metformin monotherapy: a randomised trial CNRS Inist …
type 2 diabetes on background metformin monotherapy: a randomised trial CNRS Inist …
[PDF][PDF] Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised …
FJ Lavalle-González, A Januszewicz, J Davidson… - Diabetologia, 2013 - Citeseer
Aims/hypothesis The aim of this work was to evaluate the efficacy and safety of canagliflozin
vs placebo and sitagliptin in patients with type 2 diabetes who were being treated with …
vs placebo and sitagliptin in patients with type 2 diabetes who were being treated with …
Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial
FJ Lavalle-gonzález, A Januszewicz, J Davidson… - …, 2013 - search.proquest.com
Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2
diabetes on background metfor Page 1 ARTICLE Efficacy and safety of canagliflozin compared …
diabetes on background metfor Page 1 ARTICLE Efficacy and safety of canagliflozin compared …